RGRogan A. Grant

Rogan A. Grant

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rogan A. Grant has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Aashutosh Shetti

    Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Dr. Tsujikawa is now with Department of Anesthesiology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

    1 shared publication
  • Alexander V Misharin

    Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    1 shared publication
  • Alexander V. Misharin

    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    1 shared publication
  • Ali Ö. Yildirim

    Institute of Lung Health and Immunity, Helmholtz Munich, CPC, Member of the DZL, Munich, Germany

    1 shared publication
  • Allegra Kawles

    Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    1 shared publication
  • Alyssa Macomber

    Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    1 shared publication

Latest Publications

  • Astrocyte Orai1 signaling promotes spinal excitatory synaptic potentiation and neuropathic pain after nerve injury in male mice

    by Shogo Tsujikawa, Aashutosh Shetti, Rogan A. Grant, Michaela M. Novakovic, Murali Prakriya

    Neuropathic pain after peripheral nerve injury is a multifactorial condition mediated partly by inflammation in the spinal cord that results in potentiation of excitatory synaptic transmission in nociceptive circuits. Glial cells including astrocytes are key mediators of the underlying inflammation, but the signaling checkpoints that regulate astrocyte-driven spinal cord inflammation and sensitization of nociceptive circuits are not well understood. Here, we identify Orai1-mediated store-operated Ca 2+ entry (SOCE) as an important regulator of spinal astrocyte cytokine production, metabolic reprogramming, and pain hypersensitivity in mice. Conditional deletion of Orai1 in astrocytes attenuated mechanical allodynia after nerve injury in male but not female mice, despite comparable SOCE suppression in both sexes. Orai1 deficiency also attenuated production of proinflammatory cytokines after SOCE activation, including TNFα, IL-6, and IL-33, both in vivo and in vitro. Electrophysiological recordings revealed that astrocyte Orai1 deletion prevented injury-induced enhancement of glutamatergic synaptic transmission in dorsal horn neurons, linking astrocytic Ca 2+ signaling to central sensitization. Metabolomic profiling showed that Orai1 loss disrupted glycolysis and TCA cycle intermediates while promoting accumulation of immunomodulatory metabolites such as itaconate, consistent with a less inflammatory astrocyte metabolic state. These findings identify Orai1 channels as integrators of astrocyte Ca 2+ signaling, immunometabolism, and excitatory synaptic potentiation after nerve injury, and identify a sexually dimorphic astrocyte mechanism governing neuropathic pain pathogenesis. Targeting astrocyte Orai1 channels may provide a selective therapeutic strategy for male-predominant chronic pain.

  • Open Access

    Longitudinal clinical proteomics reveals pneumonia type–specific protein biomarkers and autoantibodies

    by Anna Semenova, Taylor A. Poor, Johannes B. Müller-Reif, Sai Rama Sridatta Prakki, Phillip Geyer, Martin Mück-Häusl, Rogan A. Grant, Luke Rasmussen, Lesca M. Holdt, Daniel Teupser, et al.

    Community-acquired pneumonia is a major cause of morbidity and mortality globally. Specific molecular endotypes are currently not well defined, and different viral or bacterial pathogens may trigger specific host responses and pathogenic mechanisms. We performed longitudinal proteomic profiling of bronchoalveolar lavage fluid and plasma from bacterial, influenza, and SARS-CoV-2–driven pneumonia. Our analysis revealed highly pneumonia type–specific proteomic signatures, including COVID-19–specific antibodies locally produced in the lung. These antibodies showed biased immunoglobulin V–domain usage, linked to a CD69 / CD83 plasma cell state associated with disease severity and degree of autoimmunity. Using mass spectrometry–driven autoantibody profiling in 2 independent COVID-19 cohorts, we identified 177 putative autoantibodies targeting extracellular matrix, nuclear, and immune-related proteins. Of note, temporal changes in autoantibody profiles correlated with clinical markers of inflammation, organ dysfunction, and duration of hospitalization. These findings highlight the autoimmune aspects of COVID-19 and provide potential biomarkers and therapeutic targets to help improve patient outcomes.


  • Open Access

    SuperAging is associated with reduced age‐related cortical neuroinflammation in the absence of neuropathology

    by Karolina J Senkow, Allegra Kawles, Maxwell J Schleck, Caroline M Nelson, Grace Minogue, Rachel M Keszycki, Antonia Zouridakis, Alyssa Macomber, Molly A Mather, Rudolph J Castellani, et al.

    Background: It is well‐established that average or “normal” aging is associated with a gradual decline of memory capacity. SuperAgers are defined as unique individuals ≥80 years of age who show exceptional memory at least as good as individuals 20‐30 years their junior. The goal of this study was to identify the cellular and molecular substrates driving the vulnerability or preservation of memory during human aging. Method: We performed imaging spatial transcriptomics (Xenium, 10X Genomics) using a custom panel of 381 genes on paraffin‐embedded cortex (middle frontal gyrus) for the unbiased identification of more than 600,000 high‐quality cells encompassing multiple subtypes and cell states of neurons, glia, and endothelial cells with subcellular resolution. Brain specimens were obtained through the Northwestern University Alzheimer's Disease Research Center brain bank from the following individuals: 1) SuperAgers with intermediate Alzheimer's disease neuropathic change (ADNC; n = 2), or with only mild primary age‐related tauopathy (PART; n = 2) ; 2) Cognitively‐healthy individuals without pathology ( n = 2); and 3) individuals with clinical amnestic dementia and significant ADNC or ADNC + limbic‐predominant age‐related TDP‐43 encephalopathy (LATE‐NC), stage 2 ( n = 4). Result: We found that, in the cortex of individuals exhibiting significant postmortem neuropathology, key pro‐inflammatory glial populations emerged, including disease‐associated microglia (DAMs), oligodendrocytes characterized by NF‐κB‐responsive gene expression, and reactive astrocytes characterized by elevated expression of the monocyte and lymphocyte chemoattractant CCL2 . In SuperAgers lacking significant neuropathology at autopsy, however, these pro‐inflammatory glial subpopulations were substantially less prevalent. Abundance of these populations was also reduced relative to “normal” agers. Conclusion: These preliminary findings suggest that the SuperAging phenotype may be associated with reduced cortical neuroinflammation at the molecular and cellular level. Further, we established a novel imaging spatial transcriptomic atlas of the aging human middle frontal gyrus across abnormal and supranormal trajectories of cognitive aging.